Name: Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy (en Inglés)
Price: 518617.00 COP
Availability: InStock
Author: Asati Vivek,Vaidya Ankur
ISBN: 9780323961219

portada Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy (en Inglés)

Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy (en Inglés)

Formato

Libro Físico

Editorial

Academic Press

Autor

Asati Vivek,Vaidya Ankur

Idioma

Inglés

N° páginas

502

Encuadernación

Tapa Blanda

ISBN13

9780323961219

N° edición

Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy (en Inglés)

Asati Vivek,Vaidya Ankur (Autor) · Academic Press · Tapa Blanda

Libro Nuevo Importado

Envío: 17 a 22 días háb.

$ 942.940$ 518.617

-45%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 100 unidades

$ 518.617

¡Envío Gratis! Llega entre el 08 Sep y el 16 Sep a Bogota, Cundinamarca. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy (en Inglés)"

Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy discusses recently developed treatments based on molecular targets which are genetically altered in cancer cells and are essential for tumor development and survival. Considerable research effort has been devoted to the development of targeted drugs that inhibit the action of pathogenic kinases, and clinical studies performed so far have validated the positive effects of kinase inhibitors for cancer treatment. Each chapter discusses a molecular target, such as ALK2, ATR, CK, Src-Abl, EGFR, Fyn-Blk-Lyn, IGFs, and PAK1. The book's chapters are written by experts who actively work on the targets to help readers fully understand how they can be used. This is a valuable resource for cancer researchers, oncologists, graduate students and members of the biomedical field who are interested in the potential of novel cancer therapies based on molecular targets.